BLMH Stock Overview
Blum Holdings, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Blum Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.80 |
52 Week High | US$3.60 |
52 Week Low | US$0.10 |
Beta | 2.63 |
1 Month Change | 6.52% |
3 Month Change | 14.13% |
1 Year Change | -55.62% |
3 Year Change | -97.06% |
5 Year Change | -99.06% |
Change since IPO | -99.95% |
Recent News & Updates
Recent updates
Shareholder Returns
BLMH | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 6.5% | -2.3% | -3.7% |
1Y | -55.6% | 11.4% | 20.2% |
Return vs Industry: BLMH underperformed the US Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: BLMH underperformed the US Market which returned 20.5% over the past year.
Price Volatility
BLMH volatility | |
---|---|
BLMH Average Weekly Movement | 20.3% |
Pharmaceuticals Industry Average Movement | 9.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BLMH's share price has been volatile over the past 3 months.
Volatility Over Time: BLMH's weekly volatility has decreased from 28% to 20% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 151 | Sabas Carrillo | blumholdings.com |
Blum Holdings, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California. It also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities. The company was formerly known as Unrivaled Brands, Inc. and changed its name to Blum Holdings, Inc. in January 2024.
Blum Holdings, Inc. Fundamentals Summary
BLMH fundamental statistics | |
---|---|
Market cap | US$6.79m |
Earnings (TTM) | -US$13.82m |
Revenue (TTM) | US$33.23m |
0.2x
P/S Ratio-0.5x
P/E RatioIs BLMH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BLMH income statement (TTM) | |
---|---|
Revenue | US$33.23m |
Cost of Revenue | US$15.57m |
Gross Profit | US$17.66m |
Other Expenses | US$31.48m |
Earnings | -US$13.82m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.63 |
Gross Margin | 53.16% |
Net Profit Margin | -41.59% |
Debt/Equity Ratio | -63.6% |
How did BLMH perform over the long term?
See historical performance and comparison